Применение препаратов гиалуроновой кислоты при остеоартрозе коленных суставов

1. <div><p>Ревматология: Клинические рекомендации. М.: ГЭОТАР-Медиа, 2010.</p><p>Peat G., McCarney R., Croft P. Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis 2001;60:91-7.</p><p>Watterson J.R., Esdaile J.M. Viscosupplementation: therapeutic mechanisms and clinical potential in osteoarthritis of the knee. J Am Acad Orthop Surg 2000;8:277-84.</p><p>Bagga H., Burkhardt D., Sambrook P., March L. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol 2006;33:946-50.</p><p>Balazs E. The physical properties of synovial fluid and the specific role of hyaluronic acid. In: Helfet A.J., ed. Disorders of the Knee. Philadelphia: J.B. Lippincott, 1982;61 —74.</p><p>Kawasaki K., Ochi M., Uchio Y. et al. Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels. J Cell Physiol 1999;179:142-8.</p><p>Salter D.M., Godolphin J.L., Gourlay M.S. et al. Analysis of human articular chondrocyte CD44 isoform expression and function in health and disease. J Pathol 1996;179:396-402.</p><p>Knudson W., Loeser R.F. CD44 and integrin matrix receptors participate in cartilage homeostasis. Cell Mol Life Sci 2002;59:36-44.</p><p>Ishida O., Tanaka Y., Morimoto I. et al. Chondrocytes are regulated by cellular adhesion through CD44 and hyaluronic acid pathway. J Bone Miner Res 1997;12:1657-63.</p><p>Schiavinato A., Lini E., Guidolin D. et al. Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental model of osteoarthritis in dogs. II. Morphological findings. Clin Orthop 1989;241:286-99.</p><p>Shimizu C., Yoshioka M., Coutts R.D. et al. Long-term effects of hyaluronan on experimental osteoarthritis in the rabbit knee. Osteoarthr Cartilage 1998;6:1-9.</p><p>Wenz W., Breusch S.J., Graf J., Stratmann U. Ultrastructural findings after intraarticular application of hyaluronan in a canine model of arthropathy. J Orthop Res 2000;18:604-12.</p><p>Yoshimi T., Kikuchi T., Obara T. et al. Effects of high-molecular-weight sodium hyaluronate on experimental osteoarthrosis induced by the resection of rabbit anterior cruciate ligament. Clin Orthop 1994;298:296-304.</p><p>Guidolin D.D., Ronchetti I.P., Lini E. et al. Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500—730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee. Osteoarthr Cartilage 2001;9:371-81.</p><p>Fu L.L., Maffulli N., Chan K.M. Intra-articular hyaluronic acid following knee immobilisation for 6 weeks in rabbits. Clin Rheumatol 2001;20:98-103.</p><p>Balazs E.A., Darzynkiewicz Z. The effect of hyaluronic acid on fibroblasts, mononuclear phagocytes and lymphocytes. Biol Fibroblasts. 1973;66:237-52.</p><p>Peluso G.F., Perbellini A., Tajana G.F. The effect of high and low molecular weight hyaluronic acid on mitogen-induced lymphocyte proliferation. Curr Ther Res 1990;47:437-43.</p><p>Forrester J.V., Balazs E.A. Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 1980;40:435-46.</p><p>Pisko E.J., Turner R.A., Soderstrom L.P et al. Inhibition of neutrophil phagocytosis and enzyme release by hyaluronic acid. Clin Exp Rheumatol 1983;1:41-4.</p><p>Goto M., Hanyu T., Yoshio T. et al. Intra-articular injection of hyaluronate (SI-6601D) improves joint pain and synovial fluid prostaglandin E2 levels in rheumatoid arthritis: a multicenter clinical trial. Clin Exp Rheumatol 2001;19:377-83.</p><p>Takahashi K., Goomer R.S., Harwood F. et al. The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta (IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthr Cartilage 1999;7:182-90.</p><p>Comer J.S., Kincaid S.A., Baird A.N. et al. Immunolocalization of stromelysin, tumor necrosis factor (TNF) alpha, and TNF receptors in atrophied canine articular cartilage treated with hyaluronic acid and transforming growth factor beta. Am J Vet Res 1996;57:1488-96.</p><p>Yasui T., Akatsuka M., Tobetto K. et al. Effects of hyaluronan on the production of stromelysin and tissue inhibitor of metallopro-teinase-1 (TIMP-1) in bovine articular chondrocytes. Biomed Res 1992;13:343-8.</p><p>Pozo M.A., Balazs E.A., Belmonte C. Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative. Exp Brain Res 1997;116:3-9.</p><p>Belmonte C., Pozo M.A., Balazs E.A. Modulation by hyaluronan and its derivatives (hylans) of sensory nerve activity signaling articular pain. In: Laurent T., ed. Chemistry, Biology and Medical Applications of Hyaluronan and Its Derivatives Proceedings of the Wenner-Gren Foundation International Symposium. London: Portland Press, 1998; 205-17.</p><p>Aihara S., Murakami N., Ishii R. et al. Effects of sodium hyaluronate on the nociceptive response of rats with experimentally induced arthritis. Nippon Yakurigaku Zasshi 1992;100:359-65.</p><p>Moore A.R., Willoughby D.A. Hyaluronan as a drug delivery system for diclofenac: a hypothesis for mode of action. Int J Tissue React 1995;17:153-6.</p><p>Lo G.H., LaValley M., McAlindon T., Felson D.T. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 2003;290:3115-21.</p><p>Wang C.T., Lin J., Chang C.J. et al. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 2004;86:538-45.</p><p>Modawal A., Ferrer M., Choi H.K., Castle J.A. Hyaluronic acid injections relieve knee pain. J Fam Pract 2005;54:758-67.</p><p>Arrich J., Piribauer F., Mad P. et al. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 2005;172:1039-43.</p><p>Strand V., Conaghan P.G., Lohmander L.S. et al. An integrated analysis of five double-blind, randomized controlled trials evaluating the safety and efficacy of a hyaluronan product for intra-artic-ular injection in osteoarthritis of the knee. Osteoarthr Cartilage 2006;14:859-66.</p><p>Bannuru R.R., Natov N.S., Dasi U.R. et al. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis — meta-analysis. Osteoarthr Cartilage 2011;19:611-9.</p><p>Navarro-Sarabia F., Coronel P., Collantes E. et al. A 40-month multicentre, randomized placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis 2011;70:1957-62.</p><p>Pham T., van der Heijde D., Altman R.D. et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthr Cartilage 2004;12:389-99.</p><p>Campbell J., Bellamy N., Gee T. Differences between systematic reviews/meta-analyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee. Osteoarthr Cartilage 2007;15:1424-36.</p><p>Jorgensen A., Stengaard-Pedersen K., Simonsen O. et al. Intra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year. Ann Rheum Dis 2010;69:1097-102.</p><p>Altman R.D., Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol 1998;25:2203-12.</p><p>Clegg D.O., Reda D.J., Harris C.L. et al. Glucosamine, chon-droitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006;354:795-808.</p><p>Zhang W., Robertson J., Jones A.C. et al. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis 2008;67:1716-23.</p><p>Altman R., Brandt K., Hochberg M. et al. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthr Cartilage 1996;4:217-43.</p><p>Rovati L.C. Radiographic assessment. Introduction: existing methodology. Osteoarthr Cartilage 1999;7:427-9.</p><p>Frizziero L., Govoni E., Bacchini P. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee:clinical and morphological study. Clin Exp Rheumatol 1998;16:441-9.</p><p>Pasquali R., Guerra D., Taparelli F. et al. Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis. Rheumatology (Oxford) 2001;40:158-69.</p><p>Listrat V., Ayral X., Patarnello F. et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthr Cartilage 1997;5:153-60.</p><p>Jubb R.W., Piva S., Beinat L. et al. A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract 2003;57:467-74.</p><p>Cubukcu D., Ardic F., Karabulut N., Topuz O. Hylan G-F 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment. Clin Rheumatol 2005;24:336-41.</p><p>Anandacoomarasamy A., Bagga H., Ding C. et al. Predictors of clinical response to intraarticular Hylan injections - a prospective study using synovial fluid measures, clinical outcomes, and magnetic resonance imaging. J Rheumatol 2008;35:685-90.</p><p>Wang Y., Hall S., Hanna F. et al. Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial. BMC Musculoskelet Disord 2011;12:195.</p><p>Goldberg V.M., Buckwalter J.A. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthr Cartilage 2005;13:216-24.</p><p>Adams M.E., Atkinson M.H., Lussier A.J. et al. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal antiinflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthr Cartilage 1995;3:213-25.</p><p>Scale D., Wobig M., Wolpert W. Viscosupplementation of osteoarthritis knees with hylan: a treatment schedule study. Curr Ther Res 1994;56:220-32.</p><p>Berkowitz D. Proceedings of the United States Food and Drug Administration Advisory Panel on Orthopaedic and Rehabilitation Devices. Fairfax (VA): CASET Associates; 1996.</p><p>Reichenbach S., Blank S., Rutjes A. et al. Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and metaanalysis. Arthr Rheum 2007;57:1410-8.</p><p>Divire J.G., Zazulak B.T., Hewett T.E. Viscosupplementation for knee osteoarthritis: a systematic review. Clin Orthop Relot Res 2007;455:113-22.</p><p>Buechel F.F. The infected total knee arthroplasty: just when you thought it was over. J Arthroplasty 2004;19(Suppl 1):51-5.</p><p>Segawa H., Tsukayama D.T., Kyle R.F. et al. Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections. J Bone Joint Surg Am 1999;81-A:1434-45.</p><p>Lombardi A.V., Mallory T.H., Fada R.A. et al. Simultaneous bilateral total knee arthroplasties: who decides? Clin Orthop Rel Res 2001;392:319-29.</p><p>Weaver F., Hynes D., Hopkinson W. et al. Preoperative risks and outcomes of hip and knee arthroplasty in the Veterans Health Administration. J Arthroplasty 2003;18:693-708.</p><p>Ginsberg J.S., Turkstra F., Buller H.R. et al. Postthrombotic syndrome after hip or knee arthroplasty: a cross-sectional study. Arch Intern Med 2000;160:669-72.</p><p>Saleh K.J., Hoeffel D.P., Kassim R.A., Burstein G. Complications after revision total knee arthroplasty. J Bone Joint Surg Am 2003;85-A(Suppl 1):S71-S74.</p><p>Ohdera T., Tokunaga M., Hiroshima S. Recurrent hemarthrosis after knee joint arthroplasty: etiology and treatment. J Arthroplasty 2004;19:157-61.</p><p>Langkamer V.G. Local vascular complications after knee replacement: a review with illustrative case reports. Knee 2001;8:259-64.</p><p>Bhattacharyya T., Iorio R., Healy W.L. Rate of and risk factors for acute inpatient mortality after orthopaedic surgery. J Bone Joint Surg 2002;84-A:562-72.</p><p>Gill G.S., Mills D., Joshi A.B. Mortality following primary total knee arthroplasty. J Bone Joint Surg Am 2003;85-A:432-35.</p><p>Parvizi J., Sullivan T.A., Trousdale R.T., Lewallen D.G. Thirty-day mortality after total knee arthroplasty. J Bone Joint Surg Am 2001;83-A:1157—61.</p><p>Bell M., Fallaha M., Lenczner E. et al. Viscosupplementation with hylan G-F 20 in total knee replacement candidates: an effective pain management therapy that may delay surgery. Osteoarthr Cartilage 1999;7(Suppl A):30.</p><p>Waddell D.D., Bricker D. Hylan G-F 20 reduces the probability of progression to total knee replacement in knee osteoarthritis. Arthr Rheum 2001;44:49.</p><p>Waddell D.D., Bricker C. Total knee replacement delayed with hylan G-F 20 use in patients with grade IV osteoarthritis. JMPC 2007;13:113-21.</p><p>Turajane T., Amphansap T., Labpiboonpong V., Maungsiri S. Total knee replacement following repeated cycles of intra-articular sodium hyaluronate (500-730 Kda) in failed conservative treatment of knee osteoarthritis: a 54-month follow-up. J Med Assoc Thai 2009;92(Suppl 6):S63-S68.</p></div><br />